The prognosis of patients who are immunocompetent is generally good as they have a decreased chance of suffering from complications of the infection. Successful treatment of this condition is achieved in approximately 80% to 95% of cases.

On the other hand, immunocompromised patients with blastomycosis have poor prognosis.